Hao Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao Jiang has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
- Jintao Zhu
Huazhong University of Science and Technology (HUST)
23 shared publications Qijin Zhang
CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, Key Laboratory of Optoelectronic Science and Technology in Anhui Province, University of Science and Technology of China, Hefei, Anhui230026, P.R. China
18 shared publications- Gang Zou
State Key Laboratory of Precision and Intelligent Chemistry, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, China
17 shared publications Kehan Du
Hubei Engineering Research Center for Biomaterials and Medical Protective Materials School of Chemistry and Chemical Engineering Huazhong University of Science and Technology Wuhan P. R. China
15 shared publicationsTeng Ma
Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering
10 shared publicationsHuimin Qin
Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, School of Chemistry and Chemical Engineering
9 shared publications
Latest Publications
- Open Access
- 29 June 2026
- Published by Xia & He Publishing in Neurosurgical Subspecialties
- Vol. 2 (2) , 66-78
A Hydrophilic/Hydrophobic Janus Membrane Based on Directionally Frozen Polyvinyl Alcohol Hydrogel for Dural Defect Repair
Cerebrospinal fluid leakage and postoperative tissue adhesion are serious complications following dural injury. Current dural substitutes often lack the functional asymmetry of the native dura mater. This study aimed to develop a hydrophilic/hydrophobic Janus polyvinyl alcohol (PVA) hydrogel membrane with a directional structure and dual functionality for effective dural defect repair.
- 29 June 2026
- Published by Xia & He Publishing in Neurosurgical Subspecialties
- Vol. 2 (2) , 66-78
Open AccessA Hydrophilic/Hydrophobic Janus Membrane Based on Directionally Frozen Polyvinyl Alcohol Hydrogel for Dural Defect Repair
Cerebrospinal fluid leakage and postoperative tissue adhesion are serious complications following dural injury. Current dural substitutes often lack the functional asymmetry of the native dura mater. This study aimed to develop a hydrophilic/hydrophobic Janus polyvinyl alcohol (PVA) hydrogel membrane with a directional structure and dual functionality for effective dural defect repair.
- Open Access
- 22 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (28) , e71366
Orthogonal Design of a Guanidinocarbonyl Pyrrole‐Functionalized Pillar[5]arene‐Based Adjuvant for Synergistic Antibacterial Therapy
An orthogonal strategy is employed to synthesize the antibacterial adjuvant GCPP5 through functionalization of pillar[5]arene with guanidinocarbonyl pyrrole ( GCP ) units. This design enables the construction of a supramolecular nanoassembly ( GCPP5 ⊃ CFZ ⊃ EsY‐CN ) for multimodal treatment of Staphylococcus aureus ( S. aureus ) infections. The system integrates a membrane‐targeting GCP group, the antibiotic cefazolin ( CFZ ), and a photosensitizer eosin Y derivative ( EsY‐CN ) via host‐guest interactions, including the binding of CFZ to the nitrogen sites on the GCP moieties and the encapsulation of EsY‐CN within the electron‐rich cavity of the pillar[5]arene. These programmed interactions realize a multimodal “targeting‐chemical inhibition‐photodynamic oxidation” antibacterial strategy. Experimental results show that the photoactivated assembly effectively generates reactive oxygen species, eradicates S. aureus at extremely low concentrations (5 to 10 n m ), inhibits and eliminates biofilms, and mitigates the increase in the minimum inhibitory concentration during serial‐passage assays under the tested conditions. In vivo wound models confirm that the nanoassembly could accelerate the healing process and reduce bacterial load while exhibiting good biocompatibility. By exploiting an orthogonal supramolecular design, this work establishes a promising multimodal antimicrobial strategy for combating light‐accessible biofilm‐associated infections.
- 22 June 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (28) , e71366
Open AccessOrthogonal Design of a Guanidinocarbonyl Pyrrole‐Functionalized Pillar[5]arene‐Based Adjuvant for Synergistic Antibacterial Therapy
An orthogonal strategy is employed to synthesize the antibacterial adjuvant GCPP5 through functionalization of pillar[5]arene with guanidinocarbonyl pyrrole ( GCP ) units. This design enables the construction of a supramolecular nanoassembly ( GCPP5 ⊃ CFZ ⊃ EsY‐CN ) for multimodal treatment of Staphylococcus aureus ( S. aureus ) infections. The system integrates a membrane‐targeting GCP group, the antibiotic cefazolin ( CFZ ), and a photosensitizer eosin Y derivative ( EsY‐CN ) via host‐guest interactions, including the binding of CFZ to the nitrogen sites on the GCP moieties and the encapsulation of EsY‐CN within the electron‐rich cavity of the pillar[5]arene. These programmed interactions realize a multimodal “targeting‐chemical inhibition‐photodynamic oxidation” antibacterial strategy. Experimental results show that the photoactivated assembly effectively generates reactive oxygen species, eradicates S. aureus at extremely low concentrations (5 to 10 n m ), inhibits and eliminates biofilms, and mitigates the increase in the minimum inhibitory concentration during serial‐passage assays under the tested conditions. In vivo wound models confirm that the nanoassembly could accelerate the healing process and reduce bacterial load while exhibiting good biocompatibility. By exploiting an orthogonal supramolecular design, this work establishes a promising multimodal antimicrobial strategy for combating light‐accessible biofilm‐associated infections.
- Open Access
- 14 May 2026
- Published by Elsevier in Materials Today Advances
- Vol. 30
Advancements in hemostatic and bioactive materials for full-course wound management: From hemostasis to scar prevention
- 14 May 2026
- Published by Elsevier in Materials Today Advances
- Vol. 30
Open AccessAdvancements in hemostatic and bioactive materials for full-course wound management: From hemostasis to scar prevention
- 24 March 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 215, 21-36
Multifunctional bioactive peptide-laden and adhesion-switchable dual-crosslinked hydrogel for accelerated healing of infected deep burn wounds
- 24 March 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 215, 21-36
Multifunctional bioactive peptide-laden and adhesion-switchable dual-crosslinked hydrogel for accelerated healing of infected deep burn wounds
Proteoglycan Mimetics‐Based Antimicrobial and Anti‐Inflammatory Microneedles Restoring Dysregulated Lipid Metabolism and Suppressing Skin Atrophy for Acne Treatment
Over 15% of acne patients manifest moderate to severe clinical presentations, accompanied with bacterial infection, long‐term inflammatory responses, dysregulated lipid metabolism, and post‐acne skin atrophy. Although microneedles (MNs) represent an effective transdermal drug delivery system for acne treatment, the therapeutic effects on the restoration of dysregulated lipid metabolism and the prevention of atrophic acne scars are still lacking. Herein, we develop proteoglycan‐mimetic comb polymer (HMC)‐based dissolving microneedles (HMC‐PEP MNs) with encapsulation of therapeutic peptides. This system effectively targets the acne pathophysiological pathways involving bacterial colonization, lipid dysregulation, chronic inflammation and impaired tissue repair. Specifically, HMC enables sustained release of antimicrobial and anti‐inflammatory peptides via multiple non‐covalent interactions. HMC‐PEP MNs display significant efficacy via eradicating Cutibacterium acnes infection, suppressing pro‐inflammatory mediator expression, and reducing the TREM2/M2 macrophage ratio. Integrated transcriptomic and metabolomic analysis reveals that HMC‐PEP MNs effectively regulate cholesterol and linoleic acid metabolism, inhibit pro‐inflammatory signaling transduction, and reduce keratinocyte proliferation and differentiation by inhibiting the IGF1/IGF1R/PI3K/AKT/mTOR signaling pathway. Interestingly, HMC‐PEP MNs also promote collagen synthesis and ameliorate fibroblast dysfunction, thereby preventing the formation of post‐acne dermal atrophy. This study presents an effective therapeutic strategy for acne and elucidates the underlying mechanisms of HMC‐PEP MNs, demonstrating considerable promise for clinical translation.
Proteoglycan Mimetics‐Based Antimicrobial and Anti‐Inflammatory Microneedles Restoring Dysregulated Lipid Metabolism and Suppressing Skin Atrophy for Acne Treatment
Over 15% of acne patients manifest moderate to severe clinical presentations, accompanied with bacterial infection, long‐term inflammatory responses, dysregulated lipid metabolism, and post‐acne skin atrophy. Although microneedles (MNs) represent an effective transdermal drug delivery system for acne treatment, the therapeutic effects on the restoration of dysregulated lipid metabolism and the prevention of atrophic acne scars are still lacking. Herein, we develop proteoglycan‐mimetic comb polymer (HMC)‐based dissolving microneedles (HMC‐PEP MNs) with encapsulation of therapeutic peptides. This system effectively targets the acne pathophysiological pathways involving bacterial colonization, lipid dysregulation, chronic inflammation and impaired tissue repair. Specifically, HMC enables sustained release of antimicrobial and anti‐inflammatory peptides via multiple non‐covalent interactions. HMC‐PEP MNs display significant efficacy via eradicating Cutibacterium acnes infection, suppressing pro‐inflammatory mediator expression, and reducing the TREM2/M2 macrophage ratio. Integrated transcriptomic and metabolomic analysis reveals that HMC‐PEP MNs effectively regulate cholesterol and linoleic acid metabolism, inhibit pro‐inflammatory signaling transduction, and reduce keratinocyte proliferation and differentiation by inhibiting the IGF1/IGF1R/PI3K/AKT/mTOR signaling pathway. Interestingly, HMC‐PEP MNs also promote collagen synthesis and ameliorate fibroblast dysfunction, thereby preventing the formation of post‐acne dermal atrophy. This study presents an effective therapeutic strategy for acne and elucidates the underlying mechanisms of HMC‐PEP MNs, demonstrating considerable promise for clinical translation.
- 27 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115481
Polydopamine-sealed mesoporous silica nanocarriers loaded with organic UV filters for effective full-spectrum UV protection
- 27 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115481
Polydopamine-sealed mesoporous silica nanocarriers loaded with organic UV filters for effective full-spectrum UV protection
- Open Access
- 11 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 729
BTK-Inhibitor Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Targeting Elimination of Autoreactive BAFFRhigh B Cells
Systemic lupus erythematosus (SLE) is a chronic and refractory autoimmune disease characterized by multi-organ damage, for which reliably safe and effective treatment remains an unmet need. Autoantibodies, secreted by autoreactive B cells, deposition is the central pathogenesis of organ damage in SLE. Current studies reported B cell receptor and B cell activating factor (BAFF)-mediated signals regulate the activation and survival of B cells and production of autoantibodies. We showed that marginal zone B cells and CD11c+T-bet+ autoreactive B cells expressed higher levels of BAFF receptor and BTK in MRL/lpr mice. Here, a liposome-delivery system capable of targeting BAFFRhigh autoreactive B cells by conjugating anti-BAFFR antibody on the surface of the PEG-liposomes and loading BTK-inhibitor ibrutinib (BTEL) was rationally designed. Notably, the BTEL nanoparticles could inhibit the survival and activation of B cells, and systemic administration of BTEL could alleviate the development of the lupus mouse model by decreasing the production of anti-dsDNA autoantibodies, along with reduced secretion of inflammatory cytokines and kidney damage, and without apparent side effects. These findings suggest the potential of BTEL in targeting autoreactive B cells, blocking signaling pathways, and improving the efficacy of BTK inhibitors, providing a promising therapeutic approach for SLE, while also reducing toxicity.
- 11 January 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 729
Open AccessBTK-Inhibitor Loaded Polymeric Nanoparticles Alleviate Systemic Lupus Erythematosus by Targeting Elimination of Autoreactive BAFFRhigh B Cells
Systemic lupus erythematosus (SLE) is a chronic and refractory autoimmune disease characterized by multi-organ damage, for which reliably safe and effective treatment remains an unmet need. Autoantibodies, secreted by autoreactive B cells, deposition is the central pathogenesis of organ damage in SLE. Current studies reported B cell receptor and B cell activating factor (BAFF)-mediated signals regulate the activation and survival of B cells and production of autoantibodies. We showed that marginal zone B cells and CD11c+T-bet+ autoreactive B cells expressed higher levels of BAFF receptor and BTK in MRL/lpr mice. Here, a liposome-delivery system capable of targeting BAFFRhigh autoreactive B cells by conjugating anti-BAFFR antibody on the surface of the PEG-liposomes and loading BTK-inhibitor ibrutinib (BTEL) was rationally designed. Notably, the BTEL nanoparticles could inhibit the survival and activation of B cells, and systemic administration of BTEL could alleviate the development of the lupus mouse model by decreasing the production of anti-dsDNA autoantibodies, along with reduced secretion of inflammatory cytokines and kidney damage, and without apparent side effects. These findings suggest the potential of BTEL in targeting autoreactive B cells, blocking signaling pathways, and improving the efficacy of BTK inhibitors, providing a promising therapeutic approach for SLE, while also reducing toxicity.
- Open Access
- 10 December 2025
- Published by American Chemical Society (ACS) in Polymer Science & Technology
- Vol. 2 (4) , 198-221
Design Principles, Synthetic Strategies, and Biomedical Applications of Peptide–Polymer Conjugates
Peptides possess great potential in drug development due to their high selectivity and excellent biocompatibility, while their poor in vivo stability and short half-life limit the practical applications. Peptide–polymer conjugates, by linking peptides with synthetic or natural polymeric materials, significantly improve their pharmacokinetic properties and therapeutic efficacy. This review systematically summarizes the design principle and synthetic strategies of conjugates, including covalent bonding, physical association, and self-assembly mechanisms, and elaborates on their applications in drug delivery, immunotherapy, and tissue engineering. The review also discusses current challenges, such as difficulties in controlling conjugation sites and increased immunogenicity, and envisions the development of responsive intelligent systems to provide a theoretical basis and reference for future clinical translation of peptide-based therapeutics.
- 10 December 2025
- Published by American Chemical Society (ACS) in Polymer Science & Technology
- Vol. 2 (4) , 198-221
Open AccessDesign Principles, Synthetic Strategies, and Biomedical Applications of Peptide–Polymer Conjugates
Peptides possess great potential in drug development due to their high selectivity and excellent biocompatibility, while their poor in vivo stability and short half-life limit the practical applications. Peptide–polymer conjugates, by linking peptides with synthetic or natural polymeric materials, significantly improve their pharmacokinetic properties and therapeutic efficacy. This review systematically summarizes the design principle and synthetic strategies of conjugates, including covalent bonding, physical association, and self-assembly mechanisms, and elaborates on their applications in drug delivery, immunotherapy, and tissue engineering. The review also discusses current challenges, such as difficulties in controlling conjugation sites and increased immunogenicity, and envisions the development of responsive intelligent systems to provide a theoretical basis and reference for future clinical translation of peptide-based therapeutics.
- 17 September 2025
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (2) , 826-832
Pillararene-based AIE-active metallacycle for efficient eradication of antibiotic-resistant bacteria
- 17 September 2025
- Published by Springer Nature in Science China Chemistry
- Vol. 69 (2) , 826-832
Pillararene-based AIE-active metallacycle for efficient eradication of antibiotic-resistant bacteria
- 15 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 380, 599-614
Injectable hydrogel microspheres promoting inflammation modulation and nucleus pulposus-like differentiation for intervertebral disc regeneration
- 15 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 380, 599-614
Injectable hydrogel microspheres promoting inflammation modulation and nucleus pulposus-like differentiation for intervertebral disc regeneration